Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth CorpfiledCriticalWyeth Corp
Priority to GT200500165ApriorityCriticalpatent/GT200500165A/en
Publication of GT200500165ApublicationCriticalpatent/GT200500165A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A METABOLITOS DE INDOLILALQUILAMINA COMO LIGANDOS DE 5HIDROXITRIPTAMINA6, A COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN, A METODOS DE TRATAMIENTO QUE LOS UTILIZA, Y A METODOS PARA DETERMINAR EL METABOLISMO DE LOS DERIVADOS DE (1ARILSULFONIL1HINDOL3IL)ETILAMINA QUE LOS UTILIZA.THE PRESENT INVENTION REFERS TO METABOLITES OF INDOLILALKYLAMINE AS LIGANDS OF 5HYDROXITRIPTAMINE6, TO PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, TO METHODS OF TREATMENT THAT USES THEM, AND TO METHODS TO DETERMINE THE METABOLISM OF THE DERIVATILLING THEM.
GT200500165A2005-06-222005-06-22
INDOLILALKYLAMINE METABOLITES AS 5-HYDROXYTHYRIPTAMINE-6 LIGANDS
GT200500165A
(en)
Compounds derived from chromen-2-one; pharmaceutical composition that includes them; and their use in the treatment of a proliferative disorder such as cancer.